StockData
Lexaria Bioscience Corp. logo

Lexaria Bioscience Corp. (LEXX) stock

LEXXNasdaqPharmaceutical PreparationsFiscal year ends August 31
Financials through Q3 FY2026, quarter ended May 31, 2026Last filing: 10-Q on Jul 13, 2026Score 8/30
$4.18−0.23 (-5.22%)

Close on Nov 17, 2026Market cap $103.61MP/E –Yield –

Lexaria Bioscience price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Lexaria Bioscience's price to book ratio was 24.3× on Nov 11, 2026, against 107.0× a year earlier. Over the last 5 years it ranged from 13.1× to 150.0×, with a median of 42.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202624.3×−36.3
2025Dec 31, 202560.5×−16.1
2024Dec 31, 202476.7×+26.8
2023Dec 29, 202349.8×+22.2
2022Dec 30, 202227.6×+1.1
2021Dec 31, 202126.5×−109.2
2020Dec 31, 2020135.7×−45.8
2019Dec 31, 2019181.5×−259.7
2018Dec 31, 2018441.2×+139.1
2017Nov 30, 2017302.1×–

More Lexaria Bioscience figures

See a number that looks wrong?